37496 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Oct 07
17:10 UTC
|
MNKD
MannKind
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $6.00→ $5.00-16.7% |
|
Oct 07
17:10 UTC
|
MCK
McKesson
|
◎ Target | Michael Cherny ★★★★☆ #377 | Outperform | $1,030.00→ $1,070.00+3.9% |
|
Oct 07
17:10 UTC
|
LW
Lamb Weston
|
◎ Target | Thomas Palmer ★★★☆☆ #1297 | Neutral | $46.00→ $53.00+15.2% |
|
Oct 07
17:10 UTC
|
LSTR
Landstar System
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Hold | $185.00→ $175.00-5.4% |
|
Oct 07
17:10 UTC
|
LPLA
LPL Financial
|
◎ Target | Michael Cho ★☆☆☆☆ #2969 | Overweight | $428.00→ $445.00+4.0% |
|
Oct 07
17:10 UTC
|
LEN
Lennar
|
◎ Target | Sam Reid ★★☆☆☆ #2768 | Equal Weight | $80.00→ $75.00-6.2% |
|
Oct 07
17:10 UTC
|
JBHT
J.B. Hunt Transport Services
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Hold | $295.00→ $235.00-20.3% |
|
Oct 07
17:10 UTC
|
JAZZ
Jazz Pharmaceuticals
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $281.00→ $286.00+1.8% |
|
Oct 07
17:10 UTC
|
IP
International Paper
|
◎ Target | Gabe Hajde not yet tracked | Overweight | $46.00→ $42.00-8.7% |
|
Oct 07
17:10 UTC
|
IE
Ivanhoe Electric
|
◎ Target | Bill Peterson ★★★☆☆ #1795 | Overweight | $20.00→ $15.00-25.0% |
|
Oct 07
17:10 UTC
|
GMAB
Genmab A/S
|
◎ Target | Asthika Goonewardene ★★★★★ #115 | Buy | $40.00→ $45.00+12.5% |
|
Oct 07
17:10 UTC
|
GILD
Gilead Sciences
|
◎ Target | Chris Schott ★★★☆☆ #1343 | Overweight | $160.00→ $170.00+6.2% |
|
Oct 07
17:10 UTC
|
GILD
Gilead Sciences
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $150.00→ $158.00+5.3% |
|
Oct 07
17:10 UTC
|
FDXF
FedEx Freight
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Hold | $155.00→ $115.00-25.8% |
|
Oct 07
17:10 UTC
|
FDX
FedEx
|
◎ Target | Lucas Servera ★★★☆☆ #1715 | Buy | $365.00→ $350.00-4.1% |
|
Oct 07
17:10 UTC
|
FCX
Freeport-McMoRan
|
◎ Target | Bill Peterson ★★★☆☆ #1795 | Overweight | $77.00→ $92.00+19.5% |
|
Oct 07
17:10 UTC
|
EXPE
Expedia Group
|
◎ Target | Ken Gawrelski ★★★☆☆ #1932 | Equal Weight | $307.00→ $275.00-10.4% |
|
Oct 07
17:10 UTC
|
COR
Cencora
|
◎ Target | Michael Cherny ★★★★☆ #377 | Outperform | $380.00→ $388.00+2.1% |
|
Oct 07
17:10 UTC
|
ABNB
Airbnb
|
◎ Target | Ken Gawrelski ★★★☆☆ #1932 | Overweight | $186.00→ $185.00-0.5% |
|
Oct 07
17:10 UTC
|
AA
Alcoa
|
◎ Target | Bill Peterson ★★★☆☆ #1795 | Neutral | $52.00→ $50.00-3.8% |
|
Oct 07
16:10 UTC
|
ZS
Zscaler
|
◎ Target | Todd Weller not yet tracked | Overweight | $225.00→ $265.00+17.8% |
|
Oct 07
16:10 UTC
|
ZS
Zscaler
|
◎ Target | Saket Kalia ★★★★☆ #919 | Overweight | $220.00→ $225.00+2.3% |
|
Oct 07
16:10 UTC
|
WTW
Willis Towers Watson Public
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Equal Weight | $303.00→ $332.00+9.6% |
|
Oct 07
16:10 UTC
|
WST
West Pharmaceutical Services
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $400.00→ $440.00+10.0% |
|
Oct 07
16:10 UTC
|
WAT
Waters
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $460.00→ $500.00+8.7% |
|
Oct 07
16:10 UTC
|
VOYA
Voya Financial
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Overweight | $105.00→ $109.00+3.8% |
|
Oct 07
16:10 UTC
|
UTHR
United Therapeutics
|
◎ Target | Terence Flynn ★★★☆☆ #1851 | Equal Weight | $515.00→ $566.00+9.9% |
|
Oct 07
16:10 UTC
|
UNM
Unum Group
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Overweight | $110.00→ $109.00-0.9% |
|
Oct 07
16:10 UTC
|
TWST
Twist Bioscience
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $112.00→ $215.00+92.0% |
|
Oct 07
16:10 UTC
|
TMO
Thermo Fisher Scientific
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $650.00→ $750.00+15.4% |
|
Oct 07
16:10 UTC
|
SSMR
Sunshine Silver Mining & Refining
|
◎ Target | Carlos De Alba ★★★☆☆ #2201 | Overweight | $23.00→ $20.00-13.0% |
|
Oct 07
16:10 UTC
|
SEDG
SolarEdge Technologies
|
◎ Target | Christine Cho ★★★★★ #233 | Equal Weight | $37.00→ $36.00-2.7% |
|
Oct 07
16:10 UTC
|
SCHW
Charles Schwab
|
◎ Target | Benjamin Budish ★★★☆☆ #2230 | Overweight | $125.00→ $118.00-5.6% |
|
Oct 07
16:10 UTC
|
RVTY
Revvity
|
◎ Target | Luke Sergott ★★★★☆ #948 | Equal Weight | $115.00→ $160.00+39.1% |
|
Oct 07
16:10 UTC
|
RPRX
Royalty Pharma
|
◎ Target | Terence Flynn ★★★☆☆ #1851 | Overweight | $65.00→ $67.00+3.1% |
|
Oct 07
16:10 UTC
|
RGEN
Repligen
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $175.00→ $225.00+28.6% |
|
Oct 07
16:10 UTC
|
RGA
Reinsurance Group of America
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Overweight | $290.00→ $286.00-1.4% |
|
Oct 07
16:10 UTC
|
REGN
Regeneron Pharmaceuticals
|
◎ Target | Matthew Harrison not yet tracked | Equal Weight | $758.00→ $779.00+2.8% |
|
Oct 07
16:10 UTC
|
RCL
Royal Caribbean Cruises
|
◎ Target | Brandt Montour ★★★☆☆ #2144 | Overweight | $340.00→ $337.00-0.9% |
|
Oct 07
16:10 UTC
|
PRU
Prudential Financial
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Underweight | $92.00→ $96.00+4.3% |
|
Oct 07
16:10 UTC
|
PGR
Progressive
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Overweight | $246.00→ $247.00+0.4% |
|
Oct 07
16:10 UTC
|
PFG
Principal Financial Group
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Underweight | $92.00→ $86.00-6.5% |
|
Oct 07
16:10 UTC
|
PENG
Penguin Solutions
|
◎ Target | Tom O'Malley not yet tracked | Underweight | $40.00→ $60.00+50.0% |
|
Oct 07
16:10 UTC
|
ONC
BeOne Medicines
|
◎ Target | Gregory Renza ★★☆☆☆ #2638 | Buy | $418.00→ $420.00+0.5% |
|
Oct 07
16:10 UTC
|
NTRA
Natera
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $340.00→ $475.00+39.7% |
|
Oct 07
16:10 UTC
|
MTD
Mettler-Toledo International
|
◎ Target | Luke Sergott ★★★★☆ #948 | Overweight | $1,575.00→ $1,700.00+7.9% |
|
Oct 07
16:10 UTC
|
MRX
Marex Group plc Ordinary Shares
|
◎ Target | Benjamin Budish ★★★☆☆ #2230 | Overweight | $86.00→ $92.00+7.0% |
|
Oct 07
16:10 UTC
|
MRVL
Marvell Technology
|
◎ Target | Chris Caso ★★★★☆ #840 | Outperform | $280.00→ $375.00+33.9% |
|
Oct 07
16:10 UTC
|
MET
MetLife
|
◎ Target | Alex Scott ★★★☆☆ #1533 | Overweight | $97.00→ $111.00+14.4% |
|
Oct 07
16:10 UTC
|
MEDP
Medpace
|
◎ Target | Luke Sergott ★★★★☆ #948 | Equal Weight | $600.00→ $625.00+4.2% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.